Pharmacytimes: Condition Center: Atrial Fibrillation Atrial Fibrillation en-us Mon, 22 Dec 2014 04:18:37 EST Mon, 22 Dec 2014 04:18:37 EST Digoxin Raises Death Risk in Atrial Fibrillation Patients Digoxin is associated with a 71% increased risk of death and a 63% higher risk of hospitalization among adults diagnosed with atrial fibrillation who have no evidence of heart failure. Mon, 24 Nov 2014 12:25:01 EST Pradaxa Linked to Fewer Strokes in Atrial Fibrillation Than Warfarin Two new analyses of more than 60,000 patients found dabigatran etexilate was linked to fewer major bleeds and strokes than warfarin. Sat, 22 Nov 2014 12:53:59 EST Endurance Exercise Elevates Atrial Fibrillation Risk Is moderation the key to all things, including exercise? Tue, 18 Nov 2014 08:53:01 EST Bleeding Risk Face Off: Dabigatran Versus Warfarin As new anticoagulants for atrial fibrillation enter the marketplace, health care professionals desire to understand how the drugs compare to the tried-and-true prototype, warfarin. Mon, 03 Nov 2014 02:05:15 EST New Guidelines for Postoperative Atrial Fibrillation: Key Points for Pharmacists Updated guidelines for postoperative atrial fibrillation contain several pieces of information for pharmacists to help prevent medication errors. Tue, 14 Oct 2014 02:24:45 EDT Digoxin Carries More Than 200 Years of Controversy, Especially in Atrial Fibrillation Approximately 6.5 million Americans are prescribed digoxin, a cardiac glycoside with a long, fascinating history. Mon, 15 Sep 2014 08:25:01 EDT Atrial Fibrillation and Anticoagulation: Bleeds Happen, Antidotes Needed Several new anticoagulants have entered the US market in recent years, but research to find reversal agents for these drugs is ongoing. Tue, 26 Aug 2014 04:54:17 EDT Atrial Fibrillation Patients Prescribed Digoxin Are More Likely to Die Digoxin increases risk of death in patients with newly diagnosed atrial fibrillation. Thu, 14 Aug 2014 10:08:13 EDT Vitamin K Antagonists and Atrial Fibrillation: Time in Therapeutic Range Researchers evaluated more than 2 decades of evidence on atrial fibrillation patients taking vitamin K antagonists. Mon, 28 Jul 2014 03:56:35 EDT Anticoagulation and Risk for Falls in the Atrial Fibrillation Patient Researchers evaluated the risk of cardiovascular outcomes in atrial fibrillation patients with a history of falls. Wed, 02 Jul 2014 03:04:43 EDT Atrial Fibrillation: The Growing Cost of Hospitalization A recent investigation found a significant increase in hospitalization rates for patients with atrial fibrillation in the United States. Fri, 06 Jun 2014 04:48:40 EDT NSAIDs in the Elderly: Another Cautionary Result Current and recent users of nonsteroidal anti-inflammatory drugs were significantly more likely to develop atrial fibrillation, according to the results of a new study. Thu, 15 May 2014 09:43:42 EDT The New Atrial Fibrillation Guidelines: An In-Depth Guide New atrial fibrillation treatment guidelines from the American Heart Association and American College of Cardiology clarify the role of novel oral anticoagulants and rate/rhythm control medications. Tue, 22 Apr 2014 12:12:52 EDT Atrial Fibrillation Guidelines Updated New guidelines from the American Heart Association, American College of Cardiology, and Heart Rhythm Society address use of new oral anticoagulants as well as warfarin to treat atrial fibrillation. Thu, 10 Apr 2014 10:49:33 EDT More than Rate and Rhythm: Atrial Fibrillation and Heart Failure Management A new review summarizes the natural history of cardiomyopathies presenting with atrial fibrillation and the importance of managing underlying pathologies. Thu, 20 Mar 2014 12:36:54 EDT Challenges in Atrial Fibrillation and Heart Failure A recent article summarizes current knowledge and discusses challenges related to atrial fibrillation and heart failure. Thu, 27 Feb 2014 10:38:01 EST Atrial Fibrillation: Progression is Deadly A new analysis explores the characteristics of patients with permanent versus non-permanent atrial fibrillation, as well as those whose condition is controlled versus uncontrolled. Fri, 07 Feb 2014 12:56:34 EST The Costs of an Irregular Heartbeat A new study estimates the costs of treating atrial fibrillation as well as the comparative costs of treating it with warfarin and newer oral anticoagulants. Tue, 21 Jan 2014 03:20:01 EST CVD May Increase Risk of Cognitive Decline in Older Women The results of a recent study identified a relationship between cardiovascular disease and cognitive decline in postmenopausal women. Tue, 14 Jan 2014 05:19:01 EST Warfarin Increases Stroke Risk in Atrial Fibrillation Patients Atrial fibrillation patients were more likely to suffer a stroke within the first month of initiating treatment with warfarin when compared with those not using any antithrombotic therapy, according to the results of a recent study. Tue, 14 Jan 2014 05:10:24 EST